PARSON DROVE SURGERY — All Prescriptions & Medications — Page 12
Practice Code: D81015 | WISBECH, PE13 4LF
Showing results 551-600 of 616
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 13 | 1,300 | £129 | -73.0% ▼ | |
| 13 | 390 | £1.3K | +10.7% ▲ | |
| 13 | 210 | £1.4K | +1.8% vs avg | |
| Propafenone hydrochloride | 12 | 336 | £32 | +10.8% ▲ |
| Perindopril arginine | 12 | 360 | £72 | +1.5% vs avg |
| Indacaterol maleate | 12 | 360 | £367 | +38.3% ▲ |
| Entacapone | 12 | 1,440 | £317 | -21.3% ▼ |
| Oxytetracycline | 12 | 880 | £314 | -53.5% ▼ |
| Erythromycin ethylsuccinate | 12 | 1,400 | £117 | -48.6% ▼ |
| Fosfomycin trometamol | 12 | 12 | £55 | -57.8% ▼ |
| Quinine bisulfate | 12 | 336 | £60 | -69.1% ▼ |
| Insulin glulisine | 12 | 60 | £340 | -44.0% ▼ |
| Glucagon | 12 | 12 | £137 | -21.1% ▼ |
| Magnesium glycerophosphate | 12 | 1,040 | £358 | -12.7% ▼ |
| Pyridoxine hydrochloride | 12 | 1,008 | £418 | -44.2% ▼ |
| Ready to serve infant formula, high energy (0913104) | 12 | 168.4K | £2.0K | +8.6% ▲ |
| Ready to serve 3.3 kcal/ml higher protein dessert (0913141) | 12 | 9,912 | £230 | +99.2% ▲ |
| Tube feed 1 kcal/ml with fibre (0914011) | 12 | 266.0K | £4.5K | +16.3% ▲ |
| Heparinoid | 12 | 1,500 | £82 | -54.2% ▼ |
| Sodium chloride | 12 | 1,440 | £512 | +81.3% ▲ |
| Mupirocin | 12 | 195 | £79 | +29.3% ▲ |
| Terbinafine hydrochloride | 12 | 315 | £61 | -67.7% ▼ |
| Medicated stockings | 12 | 48 | £181 | +78.1% ▲ |
| 12 | 453 | £92 | -64.0% ▼ | |
| 12 | 60 | £113 | +1.8% vs avg | |
| 12 | 920 | £333 | -53.5% ▼ | |
| 12 | 1,200 | £172 | -62.2% ▼ | |
| 12 | 640 | £498 | -70.4% ▼ | |
| 12 | 430 | £274 | -22.1% ▼ | |
| Cimetidine | 11 | 330 | £31 | -41.0% ▼ |
| Telmisartan | 11 | 616 | £61 | -81.0% ▼ |
| Valsartan with diuretic | 11 | 308 | £231 | -17.0% ▼ |
| Prasugrel | 11 | 308 | £40 | -65.0% ▼ |
| Lacosamide | 11 | 616 | £73 | -79.5% ▼ |
| Midazolam hydrochloride | 11 | 44 | £1.0K | -23.7% ▼ |
| Safinamide | 11 | 330 | £721 | -45.4% ▼ |
| Mepacrine hydrochloride | 11 | 154 | £982 | +53.4% ▲ |
| Mebendazole | 11 | 235 | £16 | -3.9% ▼ |
| Prasterone | 11 | 336 | £179 | +66.7% ▲ |
| Phased formulations of ethinylestradiol | 11 | 231 | £15 | +146.5% ▲ |
| Tamsulosin and dutasteride hydrochloride | 11 | 330 | £91 | -68.5% ▼ |
| Powder delisted probiotic (0913531) | 11 | 330 | £328 | +61.0% ▲ |
| Miconazole | 11 | 815 | £47 | +246.1% ▲ |
| Tars | 11 | 15.2K | £935 | +31.2% ▲ |
| Co-cyprindiol (Cyprote acetate/ethinylestradiol) | 11 | 861 | £106 | +26.8% ▲ |
| Aciclovir | 11 | 78 | £70 | -10.8% ▼ |
| 11 | 110 | £389 | +66.0% ▲ | |
| 11 | 185 | £394 | -67.4% ▼ | |
| 11 | 32 | £427 | +43.8% ▲ | |
| 11 | 330 | £566 | +37.7% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.